By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure Release: Company To Report Fourth Quarter And Full Year 2016 Financial Results 1/10/2017 11:45:26 AM
NovoCure Rlease: Pharma Announces Preliminary Fourth Quarter And Full Year 2016 Operating Statistics 1/10/2017 11:42:22 AM
NovoCure’s Optune (NovoTTF-100A) Approved In Japan For The Treatment Of Newly Diagnosed Glioblastoma 12/19/2016 9:54:52 AM
NovoCure Presents Second Cohort Of Phase 2 Pilot PANOVA Trial Results Suggesting Tumor Treating Fields Plus Nab-Paclitaxel And Gemcitabine May Be Safe As First-Line Treatment And May Improve One-Year Survival Rate Of Patients With Advanced Pancreatic Cancer 12/13/2016 11:44:17 AM
NovoCure Presents Phase 2 Pilot INNOVATE Trial Results Suggesting Tumor Treating Fields Plus Paclitaxel May Be Safe As First-Line Treatment And May Improve Survival Of Patients With Recurrent Ovarian Cancer 12/13/2016 11:42:46 AM
Long-Term Analysis Of All 695 Patients Enrolled In NovoCure’s Phase 3 Pivotal Trial In Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results And Demonstrates Superior Two- And Four-Year Survival Rates 11/18/2016 11:42:05 AM
NovoCure Presents Interim STELLAR Results At IASLC Suggesting Treatment With Tumor Treating Fields Plus Chemotherapy May Extend Survival Of Patients With Mesothelioma 11/17/2016 11:26:37 AM
NovoCure Announces 38 Presentations On Tumor Treating Fields At 21st Annual Scientific Meeting Of The Society Of Neuro-Oncology 11/7/2016 11:17:43 AM
NovoCure Reports Third Quarter 2016 Financial Results And Provides Company Update 11/2/2016 10:02:19 AM
NovoCure Release: CNS Oncology Publishes Tumor Treating Fields Treatment Planning And Patient Follow-up Guidelines In Glioblastoma 9/19/2016 10:03:13 AM